Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Corbus Pharma Cmn (NASDAQ: CRBP)

$6.60 USD $0.00 (0.00%)
Last Price $6.6
Net Change $0 (0%)
Bid $6.45
Ask Price $9
Open Price $6.6
Previous Close Price $6.6
High Price $6.7
Low Price $6.5
Number of Trades 2,075
Volume 422,587
Fifty Two Week High $10.78 (2016-10-10)
Fifty Two Week Low $2.1 (2016-05-06)
Average Daily Volume 1,110,186
Share Outstanding 50,140 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-37.76
Recent Earnings $
Annual EPS $-0.49
Last Quarter EPS $
Market Capitalization $0.33B
Insider Shareholders % 0.116%
Annual Revenue $0B
No. Shares Outstanding 50,140
Inst. Shareholder % 25.73%
Annual Net Income $0B
TTM Net Profit Margin $100.19
1-Year Return 193.33%
3-Year Return 120%
5-Year Return 120%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -37.759998%
Dividends per Share $
Stock Split Ratio
Beta 2.6
Corbus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics to treat life threatening (`orphan`) inflammatory-fibrotic diseases. The Company's lead product is Resunab (TM), an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and scleroderma. Corbus Pharmaceuticals Holdings, Inc. is based in Norwood, Massachusetts.

CRBP News & Stock Updates